Incremento gradual de fibra diettica puede mejorar significativamente la regularidad intestinal
Carnosine is there to keep on reviving glutathione and vitamin C
Any persistent abnormalities should be reported to a GP or diabetes specialist nurse
Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks
Glucagon-Receptor Activity Considerations Unlike traditional GLP-1focused compounds, Retatrutide also interacts with glucagon receptors, which are researched for their potential role in: Increased energy expenditure Fat oxidation Metabolic-rate modulation This broader receptor activity may contribute to differences in appetite regulation, energy balance, and metabolic response compared to earlier incretin-based research peptides